-
R&D basebuilding area(m²)
-
Total area ofproduction base(m²)
-
API exportingcountries (number)
-
B-side businesscoverage (household)
-
million
C-side service users (person)
About Zein
重庆金沙威尼斯欢乐娱人城药业有限公司
Zein Biotechnology Co., Ltd., founded in 2001, is a national high-tech enterprise engaged in the construction of a full-life cycle management service system for drugs. We take MAH (Marketing Authorization Holder) as the core to support the registration and marketing of MAH drugs and commercial delivery with the compliance management and key technical service capabilities for the whole process of drug development, manufacturing, transaction promotion and post-marketing studies of drugs.
After 20 years of development, we have been approved to establish the “Chongqing Chiral Drugs Engineering Technology Research Center”, “Chongqing New Drug Design Engineering Technology Research Center” and “Chongqing Postdoctoral Research Workstation”. We established the national-level “Drug Advanced Manufacturing Technology National and Local Joint Engineering Research Center” together with Chongqing University. At present, the industrial achievements include 33 new drug certificates, 51 production approvals, 11 foreign invention patents (including 2 in the United States, 2 in Europe, 1 in Japan, 2 in South Korea and 1 in India) and 36 domestic invention patents.
We have built a R&D platform consisting of Liangjiang Medicine, Liujiang Pharma, Lanjiang Pharmaceutical and a clinical test research platform represented by Gerui Clinical Research Center Co., Ltd. (a Phase BE/I clinical research center that meets the GCP standards of the National Medical Products Administration) to provide integrated services for drug development and drug clinical research. We have built a CMO industrial service platform with our Changshou API Production Base and Jinfeng Preparations Production Base as the core, both of which were built in accordance with the new Chinese GMP, international cGMP and the latest safety and environmental standards. Changshou API Production Base covers an area of 82,000 square meters, and Jinfeng Preparations Production Base covers an area of 49,000 square meters. The capacity of API exceeds one hundred tons, and the preparations production lines cover normal-release and sustained-release capsules, granules, tablets and other dosage forms....
Products and servicesProducts and services
-
Youngsure ®Orlistat Capsules
- Formulations:
Capsule
- Indication:
For the treatment of obese or overweight patients (body mass index≥24)
- Strength:
60mg
Youngsure ®Orlistat Capsules
Chemical drugs
- Formulations:
-
Youngsure ®Orlistat Capsules
- Formulations:
Capsule
- Indication:
For the treatment of obese or overweight patients (body mass index≥24)
- Strength:
60mg
Youngsure ®Orlistat Capsules
Chemical drugs
- Formulations:
-
Donepezil Hydrochloride Tablets
- Formulations:
Capsule
- Indication:
For the treatment of minor, moderate or severe symptoms of Alzheimer’s disease.
- Strength:
5mg, 10mg
Donepezil Hydrochloride Tablets
Chemical drugs
- Formulations:
-
Ropinirole Hydrochloride Tablets
- Formulations:
Capsule
- Indication:
This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.
- Strength:
0.5mg, 3mg (by ropinirole)
Ropinirole Hydrochloride Tablets
Chemical drugs
- Formulations:
-
Suplatast Tosilate Granules
- Formulations:
Capsule
- Indication:
This product is suitable for the treatment of bronchial asthma
- Strength:
1g: 50mg (1g contains 50mg of suplatast tosilate)
Suplatast Tosilate Granules
Chemical drugs
- Formulations:
-
Geruishu® Metformin Hydrochloride Sustained-release Tablets
- Formulations:
Capsule
- Indication:
This product is recommended as a stand-alone treatment in combination with diet and exercise therapy to achieve glycemic control in type 2 diabetes. It can be used in combination with sulfonylureas and insulin to control blood glucose in adults.
- Strength:
0.5g
Geruishu® Metformin Hydrochloride Sustained-release Tablets
Chemical drugs
- Formulations:
-
Lingsu® Quetiapine Fumarate Sustained-Release Tablets
- Formulations:
Capsule
- Indication:
This product is used for the treatment of depressive episodes in schizophrenia and bipolar disorder.
- Strength:
200mg: 60 tablets/bottle, 20 tablets/bottle, 21 tablets/bottle, 30 tablets/bottle.
Lingsu® Quetiapine Fumarate Sustained-Release Tablets
Chemical drugs
- Formulations:
-
Saige’en ® Tropisetron Hydrochloride Injection
- Formulations:
Capsule
- Indication:
Prevent nausea and vomiting caused by cancer chemotherapy; treat nausea and vomiting after surgery.
- Strength:
Injection 2ml: 2mg; 5ml: 5mg
Saige’en ® Tropisetron Hydrochloride Injection
Chemical drugs
- Formulations:
-
Miconazole Nitrate Suppository
- Formulations:
Capsule
- Indication:
Topical treatment of dual infections caused by Candida vulvovaginosis and Gram-positive bacteria.
- Strength:
0.2g
Miconazole Nitrate Suppository
Chemical drugs
- Formulations:
News
Hotline:023-6888 9003 |
E-mail:zhienshengwu@zein-bio.com |
Address:No. 1-6, Standard Factory Building, Jinfeng Biopharmaceutical Industrial Park, No. 28 Gaoxin Avenue, High tech Zone, Chongqing |
